Amber ListRecovering

RYTMRhythm Pharmaceuticals, Inc.

Healthcare · Biotechnology · mid-cap ($5.6B)
-23.9%
from rolling 252-day high of $122.20 set 2025-12-11 · 168d ago
Current
$92.98
Decline depth
-23.9%
Decline σ
2.4σ
TFC
4/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$RYTM landed on the list 2026-03-02, down 22.3% from its 52-week high that day — now down -23.9%.

That's 5.4 percentage points deeper than the day it joined. It bottomed 38.0% below that high along the way.

Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

RYTM qualifies for the Amber List on decline depth.

Decline depth
-23.9%
From rolling 252-day high of $122.20, 168d ago. Past the 20% Watch threshold.
Time-frame continuity
4/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Past the 4/5 Amber threshold.
Decline sigma
2.4σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (3.57% per day).

The structural read

What price action says about RYTM.

RYTM qualifies for the Amber List on decline depth — down -23.9% from its rolling 252-day high.

Cross-confirmation: also showing 4/5 bearish time frames.

Alongside that decline, our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames — moderate or strong time-frame-continuity (TFC) alignment — so the ticker also carries a Recovering badge. The two readings coexist: the tier tells you how deep the damage is, the Recovering badge tells you whether momentum may be turning. Recovering is not a buy signal; it's a structural read.

Broken Stocks stops here — it flags the structure, it doesn't build the upside case. Working out whether RYTM's turn is investable is what our sister tool does: ConvictionEdge — triple-engine conviction research on names showing a recovery signal.

Upstream TFC read: strong alignment, current phase daily. Last bar types — daily 2U (green), weekly 2U (green), monthly 3 (green).

Earnings on file: 2026-05-05. Tiering is unaffected by earnings dates — listings reflect price structure only.

52-week range

52W low $55.31 56.3% of range 52W high $122.20

Sector context · Healthcare

194 other Healthcare tickers are on Broken Stocks.

89 Red List
46 Amber
59 Watch
-36.0% Median decline

Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →

Questions about RYTM

What people ask.

Why is RYTM on Broken Stocks?

RYTM qualifies for the Amber List on decline depth. It is down -23.9% from its rolling 252-day high of $122.20, set on 2025-12-11 — 168d ago. It additionally carries a Recovering badge — see below.

What does the Recovering badge mean for RYTM?

Recovering means our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames (moderate or strong time-frame continuity). It coexists with the decline tier — RYTM is still Amber List because the rolling-252-day decline hasn't healed, but a bullish setup has formed inside that decline. The two readings answer different questions: the tier tells you how deep the damage is; the Recovering badge tells you whether momentum may be turning. It's not a buy recommendation.

Is RYTM a falling knife?

No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. RYTM is down -23.9% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.

Is RYTM a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is RYTM trading inside its 52-week range?

At $92.98, RYTM sits 56.3% of the way from its 52-week low ($55.31) to its 52-week high ($122.20). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has RYTM been declining?

The current 23.9% decline accrued over 168d, which annualizes to roughly -51.9% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does RYTM compare to its sector?

There are 194 other Healthcare tickers on Broken Stocks: 89 Red, 46 Amber, 59 Watch, with 107 showing recovering structural signals. Median sector decline is -36.0% — RYTM's decline is shallower than the sector median.

Does RYTM's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-05) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.